Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Rocamora

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|June 5, 2026
LeGenD: high-throughput N-glycan profiling using explainable AI and lectin profilingHaining Li, Angelo G Peralta, Sanne Schoffelen, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived proteinFrances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 8, 2023
Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome InhibitorsJehad Almaliti, Pavla Fajtová, Jaeson Calla, et al.
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human KinasesLushun Wang, Monica J Bohmer, Jinhua Wang, et al.
Frontiers in Pharmacology|May 23, 2022
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and CancerYabalu Z Abacha, Arnold Donkor Forkuo, Stephen Y Gbedema, et al.
Cell Chemical Biology|November 23, 2023
Antiplasmodial peptaibols act through membrane directed mechanismsJennifer E Collins, Jin Woo Lee, Frances Rocamora, et al.
Science Translational Medicine|March 8, 2023
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug targetEva S Istvan, Francisco Guerra, Matthew Abraham, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 5, 2026
LeGenD: high-throughput N-glycan profiling using explainable AI and lectin profilingHaining Li, Angelo G Peralta, Sanne Schoffelen, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Glycoengineered recombinant alpha1-antitrypsin results in comparable <i>in vitro</i> and <i>in vivo</i> activities to human plasma-derived proteinFrances Rocamora, Sanne Schoffelen, Johnny Arnsdorf, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 8, 2023
Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome InhibitorsJehad Almaliti, Pavla Fajtová, Jaeson Calla, et al.
Biotechnology and Bioengineering|July 1, 2026
Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived ProteinFrances Rocamora, Chen-Lin Hsieh, Sanne Schoffelen, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human KinasesLushun Wang, Monica J Bohmer, Jinhua Wang, et al.
Frontiers in Pharmacology|May 23, 2022
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and CancerYabalu Z Abacha, Arnold Donkor Forkuo, Stephen Y Gbedema, et al.
Cell Chemical Biology|November 23, 2023
Antiplasmodial peptaibols act through membrane directed mechanismsJennifer E Collins, Jin Woo Lee, Frances Rocamora, et al.
Science Translational Medicine|March 8, 2023
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug targetEva S Istvan, Francisco Guerra, Matthew Abraham, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
Pageof 3